Efficient Pharma Management Corp.
Efficient Pharma Management Corp.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I Open-Label Study of P1101 Followed by P1801 in Advanced Solid Tumors | Advanced Solid Tumors | Enrolling by invitation | Phase 1 | 2025-07-08 | NCT07053904 | |
| A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. | Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liver Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, carcinoma, endocrine system disorder, epithelial neoplasm, hepatocellular carcinoma, kidney cancer, kidney disorder, liver disorder, malignant endocrine neoplasm, malignant pancreatic neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, renal cell carcinoma, urinary system disorder | Recruiting | Phase 1 | 2025-03-19 | NCT06883539 |